Interactome Networks in Cancer

Metabolic, protein-protein, and gene regulatory networks composed of physical and biochemical interactions between macromolecules are the three main types of interactome networks. Here is the latest research on these networks in cancer.

December 7, 2021

Patient-matched analysis identifies deregulated networks in prostate cancer to guide personalized therapeutic intervention.

American Journal of Cancer Research
Akinchan KumarHinrich Gronemeyer
December 6, 2021
Open Access

The S-palmitoylome and DHHC-PAT interactome of Drosophila melanogaster S2R+ cells indicate a high degree of conservation to mammalian palmitoylomes

BioRxiv : the Preprint Server for Biology
E. PorcellatoChristoph Metzendorf
December 6, 2021
Open Access

A Hypoxia-Associated Prognostic Gene Signature Risk Model and Prognosis Predictors in Gliomas.

Frontiers in Oncology
Feng GaoHuixiao Wang
December 6, 2021
Open Access

Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent.

Frontiers in Pharmacology
Karolina JendryczkoAnna Szlachcic
December 4, 2021

Identification of cancer-related module in protein-protein interaction network based on gene prioritization.

Journal of Bioinformatics and Computational Biology
Jingli WuGaoshi Li
December 4, 2021
Open Access

Heparan Sulfate Biosynthesis and Sulfation Profiles as Modulators of Cancer Signalling and Progression.

Frontiers in Oncology
Catarina MarquesAna Magalhães

Sign up to follow this feed and discover related papers.

Related Feeds

Adipose Tissue Heterogeneity

Examining the genomics, transcriptomics, proteomics, and metabolomics of adipose tissue at the single cell level will help build a single cell atlas of these tissues, providing insights into how changes in the map underlie health and disease states. Discover the latest research on adipose tissue heterogeneity here.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.

Alzheimer's Disease: RNA Sequencing

RNA sequencing studies have shed light on the genetic and molecular mechanisms related to the pathophysiology of Alzheimer's disease (AD). This feed follows papers using RNA sequencing technologies in Alzheimer's research.

Bioconductor Software Package: Human Cell Atlas

The open source software R / Bioconductor is used for statistical analysis and visualization, with continual generation of new analysis packages and updates. Find the latest research on single-cell and human cell atlas Bioconductor software packages here.

Bioconductor software package (programming)

The open source software R / Bioconductor is used for statistical analysis and visualization, with continual generation of new analysis packages and updates. Find the latest research on programming and Bioconductor here.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

CRISPR & Single Cell Analyses

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on CRISPR-Cas applications relevant to single cell analyses. Here is the latest research.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

© 2021 Meta ULC. All rights reserved